Flatiron Health today announced its presence at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2025 Conference, set to take place November 9-12 in Glasgow, Scotland, ...
TipRanks on MSN
BioAtla announces presentation of poster on Oz-V in OPSCC
BioAtla (BCAB) announced presentation of a poster entitled “Targeting HPV E6/E7 Upregulation of the Transmembrane Receptor Tyrosine Kinase ROR2 ...
Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback